Sarepta Therapeutics, Inc. (SRPT)
17.50
-0.07
(-0.40%)
USD |
NASDAQ |
Oct 02, 16:00
17.50
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics Price to Book Value : 1.210 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.210 |
| October 01, 2026 | 1.215 |
| September 30, 2026 | 1.260 |
| September 29, 2026 | 1.289 |
| September 28, 2026 | 1.300 |
| September 25, 2026 | 1.291 |
| September 24, 2026 | 1.271 |
| September 23, 2026 | 1.310 |
| September 22, 2026 | 1.439 |
| September 21, 2026 | 1.392 |
| September 18, 2026 | 1.390 |
| September 17, 2026 | 1.429 |
| September 16, 2026 | 1.366 |
| September 15, 2026 | 1.432 |
| September 14, 2026 | 1.446 |
| September 11, 2026 | 1.414 |
| September 10, 2026 | 1.419 |
| September 09, 2026 | 1.522 |
| September 08, 2026 | 1.448 |
| September 04, 2026 | 1.556 |
| September 03, 2026 | 1.589 |
| September 02, 2026 | 1.605 |
| September 01, 2026 | 1.475 |
| August 31, 2026 | 1.454 |
| August 28, 2026 | 1.442 |
| Date | Value |
|---|---|
| August 27, 2026 | 1.493 |
| August 26, 2026 | 1.345 |
| August 25, 2026 | 1.308 |
| August 24, 2026 | 1.253 |
| August 21, 2026 | 1.299 |
| August 20, 2026 | 1.329 |
| August 19, 2026 | 1.364 |
| August 18, 2026 | 1.246 |
| August 17, 2026 | 1.257 |
| August 14, 2026 | 1.251 |
| August 13, 2026 | 1.274 |
| August 12, 2026 | 1.271 |
| August 11, 2026 | 1.260 |
| August 10, 2026 | 1.188 |
| August 07, 2026 | 1.160 |
| August 06, 2026 | 1.160 |
| August 05, 2026 | 1.101 |
| August 04, 2026 | 1.133 |
| August 03, 2026 | 1.098 |
| July 31, 2026 | 1.027 |
| July 30, 2026 | 1.076 |
| July 29, 2026 | 1.074 |
| July 28, 2026 | 1.067 |
| July 27, 2026 | 1.098 |
| July 24, 2026 | 1.084 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Moderna, Inc. | 11.21 |
| Arrowhead Pharmaceuticals, Inc. | 19.46 |
| Beam Therapeutics, Inc. | 2.370 |
| ImmunityBio, Inc. | -- |
| Twist Bioscience Corp. | 26.53 |
Price to Book Value Related Metrics
| PS Ratio | 0.9581 |
| PEG Ratio | -0.0214 |
| Price to Free Cash Flow | 32.43 |
| Price | 17.50 |
| Earnings Yield | -16.56% |
| Market Cap | 1.848B |
| PEGY Ratio | -0.0214 |